Tag: AbbVie Inc.

Global pharma AbbVie completes acquisition of Allergan

AbbVie, a research-based global biopharmaceutical company, headquartered in North Chicago, announced that it has completed its acquisition of Allergan plc. “We are pleased to reach this important milestone for the Company, its employees, shareholders and the patients we serve,” said Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie. “Our new Allergan colleagues should be commended…

Alkem Labs to acquire API assets from AbbVie

Alkem Laboratories Ltd, a multinational pharmaceutical company, is set to acquire assets related to Active Pharmaceutical Ingredient (API) Dronabinol from United States-based AbbVie Inc. for a cash consideration of $10 million.  The expected date of completion was set to be on or before 31 st December 2019.  As per BSE filing, the company said, “This…